BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

South Korea

Samsung Epis Holdings Established as New Biotechnology Investment Holding Company Following Spin-Off from Samsung Biologics

Samsung Epis Holdings Co., Ltd.announced its establishment as a new investment holding company, following the spin-off of Samsung Bioepis Co., Ltd. from Sa...

November 04, 2025 | News

Celltrion Receives U.S. FDA Interchangeability Designation for Denosumab Biosimilars STOBOCLO® and OSENVELT®

The U.S. FDA approved STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo) as interchangeable with the ref...

November 03, 2025 | News

Everest Medicines Expands into Ophthalmology with Exclusive License for VIS-101 from Visara, a NovaBridge Subsidiary

Everest Medicines announced that it has acquired an exclusive license with Visara, Inc. (“Visara”), a subsidiary of NovaBridge Biosciences (for...

October 31, 2025 | News

SK pharmteco and LOTTE BIOLOGICS Join Forces to Build Fully Integrated Global ADC CDMO Platform

Two global CDMO leaders have joined forces to strengthen their presence in the rapidly growing antibody-drug conjugate (ADC) market. The collaboration w...

October 30, 2025 | News

Daewoong Pharmaceutical’s Bersiporocin Clears Third IDMC Safety Review, Global Phase 2 IPF Trial to Continue

Third Independent Data Monitoring Committee (IDMC) review confirms safety and continuation of the study 94 patients enrolled out of 102 planned across K...

October 28, 2025 | News

Nielsen BioSciences and Maruho Expand Licensing Agreement for CANDIN Across Key Asian Markets

Expansion of licensing agreement extends CANDIN’s development to key Asian growth markets including China, South Korea and Taiwan--and broadens the...

October 27, 2025 | News

Samsung Bioepis and Phrontline Partner to Develop Next-Generation Bispecific, Dual-Payload ADC Therapies for Solid Tumours

Samsung Bioepis and Phrontline will co-develop two investigational antibody-drug conjugate (ADC) assets directed against targets expressed in a broad r...

October 22, 2025 | News

SK Bioscience Files Clinical Trial Application in Australia for GBP511 Universal Coronavirus Vaccine

Candidate designed to protect against COVID-19 variants and broader Sarbecoviruses Phase 1/2 study to enroll ~500 healthy adults, with topline results e...

October 16, 2025 | News

Building Biopharma Resilience: Cytiva’s Joonho Choi on the Power of Connected Ecosystems

Amid global supply chain disruptions, tightening regulations, and shifting patient needs, biopharma resilience has become both a stra...

October 15, 2025 | Interview

GC Biopharma Secures Global CMO Rights for Curevo’s Recombinant Shingles Vaccine

GC Biopharma (006280.KS), a South Korean biopharmaceutical company, announced that it has signed an agreement with Curevo Vaccine to secure contract manufa...

October 14, 2025 | News

South Korean Vaxcellbio Secures Australian Patent for Next-Generation NK Cell Expansion Technology

Vaxcellbio (CEO Je-Jung Lee, MD, PhD ), a biotechnology company specializing in immuno-oncology, announced ,that it has successfully obtained an Aust...

October 14, 2025 | News

Celltrion Receives FDA Approval for EYDENZELT®, a Biosimilar to EYLEA® for Retinal Diseases

EYDENZELT® is approved for the treatment of patients with neovascular (wet) age-related macular degeneration (wAMD), macular edema following ret...

October 13, 2025 | News

Leading Scientists Unite at OrganoAsia 2a025 to Advance Organoid Research and Industrial Applications

Leading Scientists from China, Japan and South Korea Convene to Drive Organoid Research and Commercialization ACROBiosystems, tog...

October 13, 2025 | Report

Samsung Biologics Launches ExellenS™ Framework to Standardise and Accelerate Global Biomanufacturing

ExellenS TM applies optimized facility designs, equipment, and processes across all sites to ensure equivalency and speed ExellenS TM&nbs...

October 10, 2025 | News

Stay Connected